Financhill
Back

Sportradar Group AG Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison

Sell
38

SRAD
Sportradar Group AG

Last Price:
$21.21
Seasonality Move:
11.09%
Buy
75

DRUG
Bright Minds Biosciences, Inc.

Last Price:
$90.03
Seasonality Move:
-24.59%
Sell
38
Sportradar Group AG (SRAD) is a Sell

Is Sportradar Group AG a Buy, Sell or Hold?

  • The current Sportradar Group AG [SRAD] share price is $21.06. The Score for SRAD is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • SRAD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Bright Minds Biosciences, Inc. (DRUG) is a Buy

Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?

  • The current Bright Minds Biosciences, Inc. [DRUG] share price is $95.99. The Score for DRUG is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • DRUG is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SRAD Stock Price Chart

What is Sportradar Group AG's stock price today?

  • The Sportradar Group AG share price today is $21.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRAD is experiencing selling pressure, which indicates risk of future bearish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences, Inc.'s stock price today?

  • The Bright Minds Biosciences, Inc. share price today is $95.99
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRAD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 32.38 Sell
Chaikin Money Flow: -3828576 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.31 - 23.51) Sell
Bollinger Bands (100): (22.58 - 29.42) Sell

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.7 Buy
Relative Strength Index (14 RSI): 65.61 Buy
Chaikin Money Flow: 292843 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (74.33 - 88.51) Buy
Bollinger Bands (100): (45.68 - 74.86) Buy

SRAD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.98 Sell
20-day SMA: 22.99 Sell
50-day SMA: 23.11 Sell
200-day SMA: 25.66 Sell
8-day EMA: 22.59 Sell
20-day EMA: 22.86 Sell
50-day EMA: 23.57 Sell
200-day EMA: 24.17 Sell

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 83.5 Buy
20-day SMA: 83.91 Buy
50-day SMA: 69.69 Buy
200-day SMA: 45.45 Buy
8-day EMA: 85.95 Buy
20-day EMA: 81.76 Buy
50-day EMA: 72.81 Buy
200-day EMA: 51.04 Buy

Sportradar Group AG Earnings Growth & SRAD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.30 per share.

Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.93 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.27 per share, and a decrease next year of $1.59 per share.

Sportradar Group AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):